Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202871) titled 'A Study of How the Body Absorbs LY3537031' on Sept. 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Eli Lilly and Company

Condition: Healthy

Intervention: Drug: LY3537031

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: November 2025

Target Sample Size: 46

Countries of Recruitment: Singapore

To know more, visit https://clinicaltrials.gov/study/NCT07202871

Published by HT Digital Content Services with permission from Health Daily Digest....